Cargando…
Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors
Shortage of organ donors is an ongoing limiting factor in lung transplantation (LT). Despite increasing prevalence of asymptomatic COVID-19 infection, positive COVID-19 testing from a potential donor remains a contraindication at many LT centers. In this report, we present the outcomes of LT utilizi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Heart and Lung Transplantation.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794393/ https://www.ncbi.nlm.nih.gov/pubmed/36624019 http://dx.doi.org/10.1016/j.healun.2022.12.016 |
_version_ | 1784860025291800576 |
---|---|
author | Hwang, Josephine Yuen, Alexander Rhoades, Joshua Barnes, Darina Zakowski, Phillip Megna, Dominick J. Catarino, Pedro Zaffiri, Lorenzo Rampolla, Reinaldo |
author_facet | Hwang, Josephine Yuen, Alexander Rhoades, Joshua Barnes, Darina Zakowski, Phillip Megna, Dominick J. Catarino, Pedro Zaffiri, Lorenzo Rampolla, Reinaldo |
author_sort | Hwang, Josephine |
collection | PubMed |
description | Shortage of organ donors is an ongoing limiting factor in lung transplantation (LT). Despite increasing prevalence of asymptomatic COVID-19 infection, positive COVID-19 testing from a potential donor remains a contraindication at many LT centers. In this report, we present the outcomes of LT utilizing an algorithm based on donor clinical presentation, and COVID-19 real-time reverse transcription polymerase chain reaction (RT-PCR) with cycle threshold (Ct) values evaluation. The Ct value threshold for organ acceptance was >35. A total of 8 COVID-positive donors were included. No donor-to-recipient transmissions of COVID-19 were observed. Short-term outcomes were comparable to those reported in pre-COVID literature. Survival-to-date is 100% with median POD of 161 days. Our findings support the safety and efficacy of utilizing our algorithm including Ct value threshold for selection of donors with incidental COVID-19 positive testing. |
format | Online Article Text |
id | pubmed-9794393 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | International Society for Heart and Lung Transplantation. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97943932022-12-28 Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors Hwang, Josephine Yuen, Alexander Rhoades, Joshua Barnes, Darina Zakowski, Phillip Megna, Dominick J. Catarino, Pedro Zaffiri, Lorenzo Rampolla, Reinaldo J Heart Lung Transplant Brief Communication Shortage of organ donors is an ongoing limiting factor in lung transplantation (LT). Despite increasing prevalence of asymptomatic COVID-19 infection, positive COVID-19 testing from a potential donor remains a contraindication at many LT centers. In this report, we present the outcomes of LT utilizing an algorithm based on donor clinical presentation, and COVID-19 real-time reverse transcription polymerase chain reaction (RT-PCR) with cycle threshold (Ct) values evaluation. The Ct value threshold for organ acceptance was >35. A total of 8 COVID-positive donors were included. No donor-to-recipient transmissions of COVID-19 were observed. Short-term outcomes were comparable to those reported in pre-COVID literature. Survival-to-date is 100% with median POD of 161 days. Our findings support the safety and efficacy of utilizing our algorithm including Ct value threshold for selection of donors with incidental COVID-19 positive testing. International Society for Heart and Lung Transplantation. 2023-03 2022-12-28 /pmc/articles/PMC9794393/ /pubmed/36624019 http://dx.doi.org/10.1016/j.healun.2022.12.016 Text en © 2022 International Society for Heart and Lung Transplantation. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Brief Communication Hwang, Josephine Yuen, Alexander Rhoades, Joshua Barnes, Darina Zakowski, Phillip Megna, Dominick J. Catarino, Pedro Zaffiri, Lorenzo Rampolla, Reinaldo Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors |
title | Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors |
title_full | Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors |
title_fullStr | Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors |
title_full_unstemmed | Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors |
title_short | Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors |
title_sort | real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental covid-19 positive lung donors |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794393/ https://www.ncbi.nlm.nih.gov/pubmed/36624019 http://dx.doi.org/10.1016/j.healun.2022.12.016 |
work_keys_str_mv | AT hwangjosephine realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors AT yuenalexander realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors AT rhoadesjoshua realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors AT barnesdarina realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors AT zakowskiphillip realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors AT megnadominickj realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors AT catarinopedro realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors AT zaffirilorenzo realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors AT rampollareinaldo realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors |